Elsevier

Progress in Cardiovascular Diseases

Volume 60, Issue 2, September–October 2017, Pages 178-186
Progress in Cardiovascular Diseases

Approach to Acute Heart Failure in the Emergency Department

https://doi.org/10.1016/j.pcad.2017.08.008Get rights and content

Abstract

Acute heart failure (AHF) patients rarely present complaining of ‘acute heart failure.’ Rather, they initially present to the emergency department (ED) with a myriad of chief complaints, symptoms, and physical exam findings. Such heterogeneity prompts an initially broad differential diagnosis; securing the correct diagnosis can be challenging. Although AHF may be the ultimate diagnosis, the precipitant of decompensation must also be sought and addressed. For those AHF patients who present in respiratory or circulatory failure requiring immediate stabilization, treatment begins even while the diagnosis is uncertain.

The initial diagnostic workup consists of a thorough history and exam (with a particular focus on the cause of decompensation), an EKG, chest X-ray, laboratory testing, and point-of-care ultrasonography performed by a qualified clinician or technologist. We recommend initial treatment be guided by presenting phenotype. Hypertensive patients, particularly those in severe distress and markedly elevated blood pressure, should be treated aggressively with vasodilators, most commonly nitroglycerin. Normotensive patients generally require significant diuresis with intravenous loop diuretics. A small minority of patients present with hypotension or circulatory collapse. These patients are the most difficult to manage and require careful assessment of intra- and extra-vascular volume status. After stabilization, diagnosis, and management, most ED patients with AHF in the United States (US) are admitted. While this is understandable, it may be unnecessary. Ongoing research to improve diagnosis, initial treatment, risk stratification, and disposition may help ease the tremendous public health burden of AHF.

Abbreviations and Acronyms

ACC/AHA
American College of Cardiology/American Heart Association
ACEI
ace inhibitor
ACS
acute coronary syndrome
AHF
acute heart failure
ASCEND-HF
Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure
BNP
brain natriuretic peptide
BP
blood pressure
ED
emergency department
EF
ejection fraction
EKG
electrocardiogram
ESC
European Society of Cardiology
HF
heart failure
ICU
intensive care unit
IV
intravenous
IVC
inferior vena cava
IVC-CI
inferior vena cava collapsibility index
LOS
length of stay
NIPPV
non-invasive positive pressure ventilation
NTG
nitroglycerin
SBP
systolic blood pressure
STEMI
ST-elevation myocardial infarction
US
United States

Keywords

Heart failure
Acute heart failure
Decompensated heart failure
Emergency department

Statement of Conflict of Interest: see page 184.

1

Peter Pang is or has been in the last one year a Consultant for: BMS, Novartis, Trevena, scPharmaceuticals, Roche Diagnostics, Relypsa and Research Support: Roche, Novartis, AHA, NIH, PCORI, AHRQ.

View full text